Form 4: GoodRx CEO Wendy Barnes Executes RSU Vesting

GoodRx CEO Wendy Barnes acquired 277,288 shares through RSU vesting and disposed of 120,456 shares to cover tax obligations.

Summary

• CEO Wendy Barnes exercised restricted stock units (RSUs) for a total of 277,288 shares of Class A Common Stock on April 15, 2026.
• A total of 120,456 shares were withheld by the company to satisfy tax withholding requirements at a price of $2.23 per share.
• Following these transactions, the CEO holds a total of 584,825 shares of Class A Common Stock.
• The transactions relate to the vesting of previously granted equity awards.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents the routine execution of pre-existing executive compensation agreements rather than a discretionary market trade.

Positives

• The CEO maintains a significant equity stake of 584,825 shares, aligning interests with shareholders.
• The transaction reflects the standard vesting schedule of executive compensation packages.

Negatives

• The company withheld 120,456 shares to cover tax obligations, which is a standard but non-cash-generating event for the executive.

Risks

• Future share price volatility could impact the value of remaining unvested RSUs.
• Continued reliance on equity-based compensation may lead to further dilution if not managed effectively.

Future Outlook

The filing does not provide forward-looking financial guidance, as it is a disclosure of insider equity transactions.

Management Comments

• The filing contains no narrative management commentary beyond the required disclosure of transaction details.

Industry Context

StockSavvy.ai notes that executive equity vesting is a routine corporate governance event. In the digital health sector, maintaining executive alignment through equity is standard practice, though investors often monitor these filings for signals regarding management confidence in long-term valuation.

Comparison to Industry Standards

• The use of RSU vesting to compensate executives is consistent with industry standards for publicly traded technology and healthcare companies.
• The tax withholding mechanism is a standard administrative procedure for equity-based compensation plans.

Stakeholder Impact

• Shareholders should note the change in beneficial ownership, though the net impact is minimal as the shares were part of an existing compensation plan.

Next Steps

• Continued monitoring of future Form 4 filings for changes in executive ownership.

Key Dates

Keywords

GoodRx, GDRX, Insider Trading, Form 4, Executive Compensation, Equity Vesting